Loading...
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
The Primary Immune Deficiency Treatment Consortium (PIDTC) performed a retrospective analysis of 662 patients with severe combined immunodeficiency (SCID) who received a hematopoietic cell transplantation (HCT) as first-line treatment between 1982 and 2012 in 33 North American institutions. Overall...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202916/ https://ncbi.nlm.nih.gov/pubmed/30154114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-03-840702 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|